Treatment of respiratory allergy with allergy immunotherapy tablets.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 21668858.
- Also identified by DOI 10.1111/j.1398-9995.2011.02642.x.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Allergy immunotherapy tablets (AIT) have expanded the treatment options for patients suffering from respiratory allergies. Efficacy is established in adults and children for two different commercially available grass AITs. The ALK grass AIT has an efficacy comparable to subcutaneous immunotherapy (SCIT), with a proven disease-modifying effect after treatment completion. Safety profiles favour AIT over SCIT. Studies suggest that tablets in all aspects are superior to sublingual drops. AITs for other allergies including house dust mite and birch and ragweed pollen are in development.
Medical subject headings
- Allergens
- Desensitization, Immunologic
- Hypersensitivity
- Poaceae
- Pollen